Dr. Qazi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 216-444-2200Fax+1 216-445-3889
Summary
- Dr. Taha Qazi is a gastroenterologist in Boston, MA and is affiliated with multiple hospitals in the area, including Boston Medical Center, Cleveland Clinic, and Lawrence General Hospital. He received his medical degree from Indiana University School of Medicine and has been in practice 6 years. He specializes in inflammatory bowel disease.
Education & Training
Boston University Medical CenterFellowship, Advanced Inflammatory Bowel Disease, 2018 - 2019
Brigham and Women's HospitalFellowship, Gastroenterology, 2015 - 2018- Boston University Medical CenterResidency, Gastroenterology, 2011 - 2018
- Boston University Medical CenterChief Residency, Internal Medicine, 2014 - 2015
Indiana University School of MedicineClass of 2011
Certifications & Licensure
OH State Medical License 2019 - 2026
IN State Medical License 2024 - 2025
MA State Medical License 2014 - 2025
WV State Medical License 2024 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease Start of enrollment: 2021 Mar 22
Publications & Presentations
PubMed
- 2 citationsRisankizumab Is Effective for The Management of Crohn's Disease of the Pouch.Maia Kayal, Elizabeth A Spencer, Matthew Smyth, Laura Raffals, Taha Qazi
Inflammatory Bowel Diseases. 2025-03-03 - 2 citationsDiagnosis of Inflammatory Bowel Disease-Associated Peripheral Arthritis: A Systematic Review.Katherine Falloon, Zahra Dossaji, Pooja Mude, Suha Abushamma, Ashwin Ananthakrishnan
Inflammatory Bowel Diseases. 2025-03-03 - 1 citationsPostoperative Crohn's Disease Recurrence Risk and Optimal Biologic Timing After Temporary Diversion Following Ileocolic Resection.Abel Joseph, Salam P Bachour, Ravi Shah, Jessica El Halabi, Hareem Syed
Inflammatory Bowel Diseases. 2025-03-03
Press Mentions
5 Great Nutrition Apps That Can Help You Manage IBDSeptember 2nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
